GlassScriptPhysician profile
Brian L Badman
NPI 1801848783
$591,191.72
in general payments reported to CMS, 2019-2025
19 companies · $49K in 2025
The $49K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105K · 2020: $52K · 2021: $83K · 2022: $112K · 2023: $105K · 2024: $86K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $225K · Travel and Lodging: $13K · Food and Beverage: $2,647 · Entertainment: $15.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $225,073.84 |
| Travel and Lodging | $12,560.71 |
| Food and Beverage | $2,646.77 |
| Entertainment | $15.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $537,361.10 | 2019-2025 | Djo Surgical |
| Insight Medical Systems, INC. | $17,532.36 | 2023-2024 | Arvis |
| Anika Therapeutics, INC. | $12,662.13 | 2021-2024 | Integrity, Integrity Implant, Tactoset |
| Embody, INC. | $9,725.15 | 2021-2023 | |
| Shoulder Innovations, INC. | $6,759.78 | 2021-2024 | Inset System |
| Restor3d, INC. | $3,738.84 | 2023-2024 | |
| Crossroads Orthopedics, LLC | $1,268.79 | 2019-2021 | |
| Depuy Synthes Products, INC. | $877.50 | 2019 | |
| Linvatec Corporation | $318.63 | 2023-2024 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $292.71 | 2022-2025 | Osseofit |
| Stryker Corporation | $280.75 | 2019-2023 | Mako |
| Exactech, INC. | $89.91 | 2021 | |
| Wright Medical Technology, INC. | $87.76 | 2019 | |
| Parcus Medical, LLC | $86.40 | 2020 | |
| Onkos Surgical, INC. | $74.56 | 2024 | Eleos Limb Salvage System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.28 | 2019-2023 | Monovisc, Peak |
| Mf Med | $14.07 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,006.47 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Badman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.